Corrigendum: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide

Arne Astrup; Romina Carraro; N Finer; A Harper; M Kunesova; M E J Lean; L Niskanen; M F Rasmussen; A Rissanen; S Rössner; M J Savolainen; L Van Gaal

doi:10.1038/ijo.2012.192

Corrigendum: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide

Arne Astrup, Romina Carraro, N Finer, A Harper, M Kunesova, M E J Lean, L Niskanen, M F Rasmussen, A Rissanen, S Rössner, M J Savolainen, L Van Gaal

Obesity Research

3 Citations (Scopus)

Original language	English
Journal	International Journal of Obesity
Volume	37
Issue number	2
Pages (from-to)	322
Number of pages	1
ISSN	0307-0565
DOIs	https://doi.org/10.1038/ijo.2012.192
Publication status	Published - 2013

Access to Document

10.1038/ijo.2012.192

06 Original 310 corrigendum2Final published version, 315 KB
ijo2012192.pdfFinal published version, 456 KB

Cite this

Astrup, A., Carraro, R., Finer, N., Harper, A., Kunesova, M., Lean, M. E. J., Niskanen, L., Rasmussen, M. F., Rissanen, A., Rössner, S., Savolainen, M. J., & Van Gaal, L. (2013). Corrigendum: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. International Journal of Obesity, 37(2), 322. https://doi.org/10.1038/ijo.2012.192

Astrup, A, Carraro, R, Finer, N, Harper, A, Kunesova, M, Lean, MEJ, Niskanen, L, Rasmussen, MF, Rissanen, A, Rössner, S, Savolainen, MJ & Van Gaal, L 2013, 'Corrigendum: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide', International Journal of Obesity, vol. 37, no. 2, pp. 322. https://doi.org/10.1038/ijo.2012.192

@article{ecfbb1c675ca4a1993387dc354a97855,

title = "Corrigendum: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide",

author = "Arne Astrup and Romina Carraro and N Finer and A Harper and M Kunesova and Lean, {M E J} and L Niskanen and Rasmussen, {M F} and A Rissanen and S R{\"o}ssner and Savolainen, {M J} and {Van Gaal}, L",

note = "CURIS 2013 NEXS 057",

year = "2013",

doi = "10.1038/ijo.2012.192",

language = "English",

volume = "37",

pages = "322",

journal = "International Journal of Obesity",

issn = "0307-0565",

publisher = "nature publishing group",

number = "2",

}

TY - JOUR

T1 - Corrigendum: Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide

AU - Astrup, Arne

AU - Carraro, Romina

AU - Finer, N

AU - Harper, A

AU - Kunesova, M

AU - Lean, M E J

AU - Niskanen, L

AU - Rasmussen, M F

AU - Rissanen, A

AU - Rössner, S

AU - Savolainen, M J

AU - Van Gaal, L

N1 - CURIS 2013 NEXS 057

PY - 2013

Y1 - 2013

U2 - 10.1038/ijo.2012.192

DO - 10.1038/ijo.2012.192

M3 - Comment/debate

C2 - 23399800

SN - 0307-0565

VL - 37

SP - 322

JO - International Journal of Obesity

JF - International Journal of Obesity

IS - 2

ER -